Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Coproporphyrin III is a derivative of porphyrin.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | Inquiry | Inquiry |
Description | Coproporphyrin III is a derivative of porphyrin. |
In vitro | Coproporphyrin III methyl ester is repeatedly isolated in a considerable amount from both feces and urine. A great increase of coproporphyrin III excretion is unaccompanied by symptoms or signs of porphyria, metal, or chemical poisoning or liver disease [1]. In the presence of the porphyrin precursor, 5-aminolevulinate (ALA), the addition of insulin causes a striking increase in the accumulation of uroporphyrin I and coproporphyrin III. Antioxidants abolish the uroporphyrin I accumulation and increases coproporphyrin III [2]. |
In vivo | Urinary porphyrin and DMA profile can be used as an early warning biomarker for chronic MMA exposure before the onset of cancer. After 4 weeks the level of coproporphyrin III concentration significantly increases in all the treatment groups compared to the control [3]. |
Synonyms | Zincphyrin |
Molecular Weight | 654.72 |
Formula | C36H38N4O8 |
CAS No. | 14643-66-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 83.3 mg/mL (127.23 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Coproporphyrin III 14643-66-4 Others Zincphyrin inhibitor inhibit